Inhalation device
Latest AstraZeneca AB Patents:
- Method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof
- Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases
- Dendrimer formulations
- GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
- PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
Description
FIG. 1 is a front perspective view from above and one side of an inhalation device showing our new design.
FIG. 2 is a front perspective view from above and one side of the inhalation device shown in FIG. 1, showing the inhalation with its cap removed.
FIG. 3 is a front elevational view thereof.
FIG. 4 is a rear elevational view thereof.
FIG. 5 is a top plan view thereof.
FIG. 6 is a bottom plan view thereof.
FIG. 7 is a right side elevational view thereof.
FIG. 8 is a left side elevational view thereof; and,
FIG. 9 is a partial enlarged top plan view thereof.
Claims
The ornamental design for an inhalation device, as shown and described.
Referenced Cited
U.S. Patent Documents
5899200 | May 4, 1999 | McNary |
6155251 | December 5, 2000 | Hauser |
6234168 | May 22, 2001 | Bruna |
6283365 | September 4, 2001 | Bason |
D473640 | April 22, 2003 | Cuffaro et al. |
D480474 | October 7, 2003 | Bowman et al. |
6672304 | January 6, 2004 | Casper et al. |
6718972 | April 13, 2004 | O'Leary |
6752145 | June 22, 2004 | Bonney et al. |
20040226555 | November 18, 2004 | Scarrott et al. |
Patent History
Patent number: D529605
Type: Grant
Filed: Dec 28, 2004
Date of Patent: Oct 3, 2006
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Laurence Huxham (Loughborough), Darren Hodson (Loughborough), William Treneman (Dry Drayton), Nick Harrison (Oakington), Martin Bunce (Marlborough), William Davis (Marlborough)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Fish & Richardson P.C.
Application Number: 29/220,195
Type: Grant
Filed: Dec 28, 2004
Date of Patent: Oct 3, 2006
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Laurence Huxham (Loughborough), Darren Hodson (Loughborough), William Treneman (Dry Drayton), Nick Harrison (Oakington), Martin Bunce (Marlborough), William Davis (Marlborough)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Fish & Richardson P.C.
Application Number: 29/220,195
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)